You have no items in your shopping cart.
Cellular Fundamentals Protocol
Cellular Fundamentals Protocol™
Energy Signalling. Mitochondrial Control. Inflammatory Balance.
NAD+ · MOTS-c · KPV · AOD9604
The Cellular Fundamentals Protocol™ is a research framework built around four compounds frequently examined in scientific literature relating to cellular energy systems, mitochondrial signalling, inflammatory pathway models, and metabolic regulation research. Supplied strictly for in-vitro laboratory investigation.
Designed Around Core Cellular Systems
This protocol maps to four foundational biological domains commonly studied in experimental systems: NAD+ as a redox coenzyme and signalling substrate (sirtuins, PARPs, salvage pathway biology); MOTS-c as a mitochondrial-derived metabolic signalling peptide (AMPK-related research); KPV as a minimal inflammation-modulating sequence (NF-κB signalling models); and AOD9604 as a modified hGH fragment studied in adipose signalling research.
NAD+
Redox & Enzyme Substrate Research
NAD+ functions as a foundational coenzyme in redox reactions and serves as a substrate for NAD+-consuming enzymes including sirtuins and PARPs. Research frequently examines its role within DNA repair signalling, transcriptional regulation, and salvage pathway dynamics in controlled laboratory models.
Established cellular biochemistry; translational context model-dependent.
MOTS-c
Mitochondrial-Derived Signalling Research
MOTS-c is investigated as a mitochondrial-encoded peptide associated with metabolic stress signalling pathways. Literature often references AMPK-related mechanisms and nuclear transcriptional responses within experimental systems examining mitochondrial adaptation.
Strong preclinical foundation; human research investigational.
KPV
Inflammatory Pathway Research (NF-κB Context)
KPV (Lys-Pro-Val) is studied as a minimal sequence derived from α-MSH and examined in experimental models focused on inflammatory signalling modulation, particularly within epithelial and immune cellular systems.
Preclinical emphasis; mechanistic research focus.
AOD9604
hGH Fragment & Adipose Signalling Research
AOD9604 is a modified C-terminal fragment associated with human growth hormone research. Preclinical literature explores lipid metabolism signalling and β-adrenergic pathway context. Historical human development programmes reported mixed efficacy outcomes.
Robust preclinical exploration; mixed historical clinical findings.
Research Context & Supply Position
Precision in Supply.
Discipline in Research.
The Cellular Fundamentals Protocol™ is presented for scientific context only. Mechanisms described reflect experimental literature and should not be interpreted as clinical claims. Axiom supplies all compounds strictly for in-vitro laboratory research.
View Research CompoundsCompliance Position
Axiom products are not approved medicines and are not intended for human consumption, medical treatment, or diagnostic use.
Not for human consumption
Not for medical use
In-vitro research only
Compliance enforced
Controlled. Considered. Engineered.
